1. Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin. (June 2022) Authors: Paukner, Susanne; Goldberg, Lisa; Alexander, Elizabeth; Das, Anita F.; Heinrich, Stefanie; Patel, Pritty; Moran, Gregory J.; Sandrock, Christian; File, Thomas M.; Vidal, Jorge E.; Waites, Ken B.; Gelone, Steven P.; Schranz, Jennifer Journal: Journal of global antimicrobial resistance Issue: Volume 29(2022) Page Start: 434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗